Dec 31, 2020

Revolution Medicines Q4 2020 Earnings Report

Total Revenue
$8.75M
Previous year: $12.1M
-27.6%
EPS
-$0.52
Previous year: -$6.52
-92.0%
Gross Profit
-$28.3M
Previous year: -$15.4M
+83.5%
Cash and Equivalents
$104M
Free Cash Flow
-$26.2M
Total Assets
$567M

Revolution Medicines

Revolution Medicines